Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery

Transactions of the American Ophthalmological Society

Volumn 104, Issue , 2006, Pages 149-159

  Dayani, Pouya N ^a   Grand, M Gilbert ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CLOPIDOGREL; ROFECOXIB; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CHOROID DETACHMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPHEMA; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; VITRECTOMY; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; VITRECTOMY; VITREOUS HEMORRHAGE; WARFARIN;

EID: 33947684831     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Freedman MD. Oral anticoagulants: pharmacodynamics, clinical indications and adverse effects. J Clin Pharmacol 1992;32:196-209.
2. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204S-223S.
3. Becker DM, Humphries JE, Walker FB, et al. Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993;117:602-605.
4. Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med 1986;314:1298-1304.
5. Fitzmaurice DA, Blann AD, Lip GY. Bleeding risks of antithrombotic therapy. BMJ 2002;325:828-831.
6. Veeger NJ, Piersma-Wichers M, Tijssen JG, et al. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol 2005;128:513-519.
7. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002;325:1073-1075.
8. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med 1995;333:5-10.
9. Torn M, van der Meer FJ, Rosendaal FR. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. Arch Intern Med 2004;164:668-673.
10. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004;147:3-15.
11. Dunn A. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med 2003;163:901-908.
12. Coon WW, Willis PW. Recurrence of venous thromboembolism. Surgery 1973;73:823-827.
13. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
14. Rockson SG, Albers GW. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 2004;43:929-935.
15. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-1511.
16. Rotenstreich Y, Rubowitz A, Segev F, et al. Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg 2001;27:1344-1356.
17. Poller L, Thomson J. Evidence for "rebounds" hypercoagulability after stopping anticoagulants. Lancet 1964;39:62-64.
18. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants: a prospective study. Thromb Haemost 1994;72:222-226.
19. Genewin U, Haeberli A, Straub PW, et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996;92:479-485.
20. Rustad H, Myhre E. Surgery during anticoagulant treatment. The risk of increased bleeding in patients on oral anticoagulant treatment. Acta Med Scand 1963;173:115-119.
21. McIntyre H. Management, during dental surgery, of patients on anticoagulants. Lancet 1966;2:99-100.
22. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998;158:1610-1616.
23. Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 2000;85:708-711.
24. Gainey SP, Robertson DM, Fay W, et al. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol 1989;108:142-146.
25. Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 2003;81:38-40.
26. Tuli SS, WuDunn D, Ciulla TA, et al. Delayed suprachoroidal hemorrhage after glaucoma filtration procedures. Ophthalmology 2001;108:1808-1811.
27. Arnold PN. Study of acute intraoperative suprachoroidal hemorrhage. J Cataract Refract Surg 1992;18:489-494.
28. McCormack P, Simcock PR, Tullo AB. Management of the anticoagulated patient for ophthalmic surgery. Eye 1993;7(Pt 6):749-750.
29. Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol 2000;28:419-422.
30. Carter K, Miller KM. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 1998;24:1361-1366.
31. Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 2004;110:1784-1788.
32. Custer PL, Trinkhaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 2002;18:409-415.
33. Hall DL, Stein WH Jr, Drummond JW, et al. Anticoagulants and cataract surgery. Ophthalmic Surg 1988;19:221-222.
34. McMahan LB. Anticoagulants and cataract surgery. J Cataract Refract Surg 1988;14:569-571.
35. Robinson GA, Mylander A. Warfarin and cataract extraction. Br J Ophthalmol 1989;73:702-703.
36. Bartley GB. Oculoplastic surgery in patients receiving warfarin: suggestions for management. Ophthal Plast Reconstr Surg 1996;12:229-230.
37. Saitoh AK, Saitoh A, Taniguchi H, et al. Anticoagulation therapy and ocular surgery. Ophthalmic Surg Lasers 1998;29:909-915.
38. Jonas JB, Pakdaman B, Sauder G. Cataract surgery under systemic anticoagulant therapy with Coumadin. Eur J Ophthalmol 2006;16:30-32.
39. Flaxel CJ, Blach RK. Aspirin is a hazard for vitreoretinal surgery [letter]. Br J Ophthalmol 1996;80:486.
40. van Dijk KN, Plat AW, van Dijk AA, et al. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genetype. Thromb Haemost 2004;91:95-101.
41. Chow DR, de Bustros S. Control of perioperative bleeding in vitreoretinal surgery. In: Ryan SJ, ed. Retina. 4th ed. Philadelphia: Elsevier; 2006:2451-2461.